VistaGen Therapeutics, Inc. (VTGN)
USD 2.24
(-1.75%)
USD 2.24
(-1.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -117.04 Million USD | -740.98% |
| 2023 | -13.91 Million USD | 78.62% |
| 2022 | -65.09 Million USD | 34.5% |
| 2021 | -99.38 Million USD | -3731.74% |
| 2020 | 2.73 Million USD | 121.0% |
| 2019 | -13.03 Million USD | -26.39% |
| 2018 | -10.31 Million USD | -261.56% |
| 2017 | -2.85 Million USD | -699.83% |
| 2016 | -356.6 Thousand USD | -102.51% |
| 2015 | 14.19 Million USD | 104.95% |
| 2014 | 6.92 Million USD | 47.06% |
| 2013 | 4.7 Million USD | 46.86% |
| 2012 | 3.2 Million USD | 251015.49% |
| 2011 | -1278.00 USD | -2182.14% |
| 2010 | -56.00 USD | 99.74% |
| 2009 | -21.31 Thousand USD | -22333.68% |
| 2008 | -95.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -124.3 Million USD | -252.85% |
| 2024 FY | -117.04 Million USD | -740.98% |
| 2024 Q4 | -117.04 Million USD | 5.84% |
| 2024 Q2 | -35.22 Million USD | -455.82% |
| 2024 Q1 | -6.33 Million USD | 54.46% |
| 2023 Q1 | -48 Million USD | 26.26% |
| 2023 Q4 | -13.91 Million USD | 36.42% |
| 2023 Q2 | -31.72 Million USD | 33.92% |
| 2023 Q3 | -21.89 Million USD | 30.99% |
| 2023 FY | -13.91 Million USD | 78.62% |
| 2022 Q1 | -94.14 Million USD | 5.28% |
| 2022 Q2 | -90.08 Million USD | 4.31% |
| 2022 Q3 | -80.55 Million USD | 10.57% |
| 2022 Q4 | -65.09 Million USD | 19.19% |
| 2022 FY | -65.09 Million USD | 34.5% |
| 2021 FY | -99.38 Million USD | -3731.74% |
| 2021 Q4 | -99.38 Million USD | 1.04% |
| 2021 Q1 | 2.97 Million USD | 8.52% |
| 2021 Q2 | -11.07 Million USD | -472.91% |
| 2021 Q3 | -100.43 Million USD | -806.79% |
| 2020 FY | 2.73 Million USD | 121.0% |
| 2020 Q2 | 263.7 Thousand USD | 106.93% |
| 2020 Q3 | 3.11 Million USD | 1080.93% |
| 2020 Q4 | 2.73 Million USD | -12.12% |
| 2020 Q1 | -3.8 Million USD | 70.79% |
| 2019 Q1 | -7.03 Million USD | 31.74% |
| 2019 Q3 | -6.22 Million USD | 19.2% |
| 2019 Q2 | -7.7 Million USD | -9.47% |
| 2019 Q4 | -13.03 Million USD | -109.34% |
| 2019 FY | -13.03 Million USD | -26.39% |
| 2018 FY | -10.31 Million USD | -261.56% |
| 2018 Q4 | -10.31 Million USD | 20.52% |
| 2018 Q3 | -12.97 Million USD | -688.3% |
| 2018 Q2 | -1.64 Million USD | -13.6% |
| 2018 Q1 | -1.44 Million USD | 49.2% |
| 2017 Q4 | -2.85 Million USD | 34.22% |
| 2017 Q2 | -6.18 Million USD | 26.3% |
| 2017 Q3 | -4.33 Million USD | 29.9% |
| 2017 FY | -2.85 Million USD | -699.83% |
| 2017 Q1 | -8.39 Million USD | -2253.65% |
| 2016 Q3 | -1.05 Million USD | -90.06% |
| 2016 FY | -356.6 Thousand USD | -102.51% |
| 2016 Q2 | -554.5 Thousand USD | -143.83% |
| 2016 Q1 | 1.26 Million USD | -91.09% |
| 2016 Q4 | -356.6 Thousand USD | 66.16% |
| 2015 Q3 | 11.88 Million USD | 6.51% |
| 2015 FY | 14.19 Million USD | 104.95% |
| 2015 Q4 | 14.19 Million USD | 19.39% |
| 2015 Q2 | 11.16 Million USD | 35.35% |
| 2015 Q1 | 8.24 Million USD | 19.08% |
| 2014 Q1 | 5.57 Million USD | 18.32% |
| 2014 Q4 | 6.92 Million USD | 8.81% |
| 2014 FY | 6.92 Million USD | 47.06% |
| 2014 Q3 | 6.36 Million USD | 7.17% |
| 2014 Q2 | 5.93 Million USD | 6.59% |
| 2013 Q2 | 3.2 Million USD | -4.11% |
| 2013 Q1 | 3.34 Million USD | 4.26% |
| 2013 Q3 | 5.22 Million USD | 62.89% |
| 2013 FY | 4.7 Million USD | 46.86% |
| 2013 Q4 | 4.7 Million USD | -9.82% |
| 2012 Q3 | 3.14 Million USD | -50.44% |
| 2012 FY | 3.2 Million USD | 251015.49% |
| 2012 Q1 | 2.53 Million USD | 45407.12% |
| 2012 Q2 | 6.34 Million USD | 150.48% |
| 2012 Q4 | 3.2 Million USD | 2.0% |
| 2011 Q4 | -5590.00 USD | -337.4% |
| 2011 FY | -1278.00 USD | -2182.14% |
| 2011 Q1 | -1359.00 USD | 54.91% |
| 2011 Q2 | -1732.00 USD | -27.45% |
| 2011 Q3 | -1278.00 USD | 26.21% |
| 2010 Q2 | -2542.00 USD | -143.95% |
| 2010 Q4 | -3014.00 USD | -5282.14% |
| 2010 Q3 | -56.00 USD | 97.8% |
| 2010 Q1 | -1042.00 USD | 72.95% |
| 2010 FY | -56.00 USD | 99.74% |
| 2009 Q2 | -156.00 USD | -162.15% |
| 2009 Q3 | -21.31 Thousand USD | -13561.54% |
| 2009 Q4 | -3852.00 USD | 81.93% |
| 2009 Q1 | 251.00 USD | 35.68% |
| 2009 FY | -21.31 Thousand USD | -22333.68% |
| 2008 FY | -95.00 USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | 185.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -109.235% |
| Alkermes plc | -166.73 Million USD | 29.803% |
| Agenus Inc. | 274.13 Million USD | 142.696% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 106.259% |
| Aptorum Group Limited | 1.35 Million USD | 8725.058% |
| Ardelyx, Inc. | 34.51 Million USD | 439.146% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2834.72% |
| Bicycle Therapeutics plc | -481.46 Million USD | 75.69% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 423.662% |
| ChromaDex Corporation | -24.04 Million USD | -386.718% |
| Chimerix, Inc. | -25.51 Million USD | -358.698% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1779.746% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -394.345% |
| CRISPR Therapeutics AG | -150.84 Million USD | 22.406% |
| Precision BioSciences, Inc. | -85.41 Million USD | -37.04% |
| Dyadic International, Inc. | -6.37 Million USD | -1735.124% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -634.614% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1627.019% |
| Lantern Pharma Inc. | -21.7 Million USD | -439.301% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -5.889% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1270.053% |
| Incyte Corporation | -3.17 Billion USD | 96.314% |
| IO Biotech, Inc. | -140.69 Million USD | 16.811% |
| Jaguar Health, Inc. | 29.39 Million USD | 498.238% |
| Novavax, Inc. | -298.29 Million USD | 60.762% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2293.105% |
| Opthea Limited | 28.15 Million USD | 515.684% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -597.159% |
| ContextLogic Inc. | -232 Million USD | 49.549% |
| MiMedx Group, Inc. | -33.9 Million USD | -245.258% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1248.073% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -4951.56% |
| NextCure, Inc. | -6.47 Million USD | -1707.102% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -131.77% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1734.864% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1062.291% |
| Vaxcyte, Inc. | -368.22 Million USD | 68.214% |
| PDS Biotechnology Corporation | -32.7 Million USD | -257.841% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 777.428% |
| Pharming Group N.V. | 109.8 Million USD | 206.595% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -572.833% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 33.204% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -532.003% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -532.003% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1548.535% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1897.372% |
| Acelyrin, Inc. | -216.9 Million USD | 46.038% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1986.282% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -6689.211% |
| Summit Therapeutics Inc. | 34.67 Million USD | 437.561% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1620.506% |
| Senti Biosciences, Inc. | 1.74 Million USD | 6826.782% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 36.597% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -51.123% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1830.815% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 117417.002% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 18737.898% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 30.426% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 205.57% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1440.89% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 9.347% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1797.648% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 51.706% |
| Immix Biopharma, Inc. | -17.5 Million USD | -568.46% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 63.042% |
| MEI Pharma, Inc. | -3.7 Million USD | -3059.136% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1035.545% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 172.366% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 521.135% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1627.019% |
| Precigen, Inc. | -481 Thousand USD | -24233.888% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 931.234% |
| AlloVir, Inc. | -62.69 Million USD | -86.7% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -110.461% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 289.806% |
| ImmuCell Corporation | 10.99 Million USD | 1164.968% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 24.068% |
| Onconetix, Inc. | 5.33 Million USD | 2295.393% |
| PureTech Health plc | -167.19 Million USD | 29.995% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -284.261% |
| Elevation Oncology, Inc. | -19.11 Million USD | -512.229% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2284.315% |
| Seer, Inc. | -4.24 Million USD | -2660.519% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -386.941% |
| Innoviva, Inc. | 255.56 Million USD | 145.799% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -109.52% |
| ESSA Pharma Inc. | -33.62 Million USD | -248.128% |
| GlycoMimetics, Inc. | -40.98 Million USD | -185.587% |
| GT Biopharma, Inc. | -1.02 Million USD | -11363.859% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -72.678% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 291.074% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 12.704% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -744.732% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -305.396% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -155269.422% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -279.256% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1328.286% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3640.662% |
| Soligenix, Inc. | -4.95 Million USD | -2263.803% |
| Century Therapeutics, Inc. | 847 Thousand USD | 13918.89% |
| Kura Oncology, Inc. | -20.11 Million USD | -481.797% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -185.994% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1293.737% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 6525.115% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3561.12% |
| Autolus Therapeutics plc | -186.59 Million USD | 37.274% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -137.397% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 57.56% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 441.561% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 171.21% |
| GRI Bio, Inc. | -1.79 Million USD | -6424.303% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1202.966% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -251.944% |
| IGM Biosciences, Inc. | -72.6 Million USD | -61.207% |
| INmune Bio, Inc. | -25.41 Million USD | -360.612% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 177.539% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -131.047% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -620.311% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3957.158% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 407.894% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -184.196% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 467.088% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 130.969% |
| Verastem, Inc. | -37.27 Million USD | -213.981% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1190.047% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -125.687% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -673.347% |
| Histogen Inc. | -7.48 Million USD | -1463.323% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -441.709% |
| Surrozen, Inc. | -32.66 Million USD | -258.333% |
| Organovo Holdings, Inc. | -1.5 Million USD | -7666.821% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2684.497% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 717.324% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 4574.235% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2916.314% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1296.539% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -169.431% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -702.958% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 63.052% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -16110.01% |
| Apollomics, Inc. | -27.39 Million USD | -327.253% |
| Amarin Corporation plc | -191.04 Million USD | 38.732% |
| Mesoblast Limited | 55.96 Million USD | 309.149% |
| Turnstone Biologics Corp. | -14.58 Million USD | -702.564% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -362.779% |
| Synaptogenix, Inc. | -28.66 Million USD | -308.374% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -12404.915% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 340.183% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -13477.02% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1510.855% |
| Exelixis, Inc. | -73.05 Million USD | -60.227% |
| Better Therapeutics, Inc. | -860 Thousand USD | -13510.0% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -387.428% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 51.508% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 16001.563% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1473.593% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 9433.812% |
| Gritstone bio, Inc. | 39.49 Million USD | 396.394% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -39.173% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4346.8% |
| Avid Bioservices, Inc. | 169.72 Million USD | 168.961% |
| Insmed Incorporated | 721.62 Million USD | 116.22% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1180.379% |
| MediWound Ltd. | -5.32 Million USD | -2099.286% |
| OmniAb, Inc. | 9.2 Million USD | 1371.824% |
| Alector, Inc. | -35.63 Million USD | -228.44% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 236.146% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2275.122% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 984.1% |
| Zai Lab Limited | -775 Million USD | 84.897% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 134.369% |
| Aura Biosciences, Inc. | -21.52 Million USD | -443.768% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -41.908% |
| Immunic, Inc. | -45.34 Million USD | -158.152% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 39.422% |
| Veracyte, Inc. | -203.82 Million USD | 42.575% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 118.337% |
| FibroGen, Inc. | 56.76 Million USD | 306.187% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1414.385% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4040.17% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -5553.446% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.55% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3403.322% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 29.475% |
| TG Therapeutics, Inc. | 17.86 Million USD | 755.279% |
| Galecto, Inc. | -21.21 Million USD | -451.687% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -392.1% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 107.458% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -378.285% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -917.172% |
| XBiotech Inc. | -200.02 Million USD | 41.484% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -39.173% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2684.938% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -231.923% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -51.579% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2156.686% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 31.317% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -26.709% |
| Vaxxinity, Inc. | 10.13 Million USD | 1255.211% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 115.897% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -987.025% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -77.461% |
| NexImmune, Inc. | -3.13 Million USD | -3635.141% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3290.011% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -674.552% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -331.904% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1203.981% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -93856.251% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -188.49% |
| Ainos, Inc. | 4.07 Million USD | 2970.232% |
| Pluri Inc. | 22.82 Million USD | 612.708% |
| Prothena Corporation plc | -608.34 Million USD | 80.76% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 1.44% |
| Celularity Inc. | 65.19 Million USD | 279.546% |
| Rallybio Corporation | -24.1 Million USD | -385.628% |
| Cue Biopharma, Inc. | -33.81 Million USD | -246.095% |
| MeiraGTx Holdings plc | -40.3 Million USD | -190.422% |
| Omeros Corporation | 331.17 Million USD | 135.343% |
| Humacyte, Inc. | -22.48 Million USD | -420.528% |
| Immunocore Holdings plc | -358.59 Million USD | 67.36% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -376.281% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -278.777% |
| Blueprint Medicines Corporation | 702.83 Million USD | 116.653% |
| CalciMedica, Inc. | -5.53 Million USD | -2016.564% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 37.814% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1045.937% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -192.345% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -251.986% |
| Pulmatrix, Inc. | -10.41 Million USD | -1023.606% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1858.273% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -206.869% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -5.066% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -95.259% |
| Cytokinetics, Incorporated | 642.37 Million USD | 118.221% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1910.064% |
| Nutriband Inc. | -251.65 Thousand USD | -46410.131% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -243.052% |
| Vor Biopharma Inc. | 4.3 Million USD | 2822.0% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.061% |
| Evogene Ltd. | -19.63 Million USD | -496.139% |
| ProKidney Corp. | -56.23 Million USD | -108.134% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -140.479% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1167.117% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 108.582% |
| CorMedix Inc. | -43.05 Million USD | -171.868% |
| BioLineRx Ltd. | 7.33 Million USD | 1695.502% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -326.164% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 353.637% |
| Atai Life Sciences N.V. | -28.55 Million USD | -309.854% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 5347.455% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -413.0% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 759.972% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -55.908% |
| MediciNova, Inc. | -50.78 Million USD | -130.48% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -48.526% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -520220.071% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1713.939% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 41.425% |
| Biomea Fusion, Inc. | -166.57 Million USD | 29.732% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 34.602% |
| Mereo BioPharma Group plc | -51.46 Million USD | -127.411% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -23.409% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 60.156% |
| Absci Corporation | -72.59 Million USD | -61.225% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2663.425% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 50.074% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -24.238% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -22.31% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -199.557% |
| Allakos Inc. | -24.97 Million USD | -368.653% |
| Imunon, Inc. | -4.21 Million USD | -2677.649% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -693.963% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 13.555% |
| BioAtla, Inc. | -109.01 Million USD | -7.371% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 16001.563% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -12364.963% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1078.155% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -452.026% |
| XOMA Corporation | -29 Million USD | -303.607% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -606.8% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1198.203% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1471.298% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 6.09% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 43.772% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -43.125% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -26.177% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -13522.926% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2944.109% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7312.196% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 108.476% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -9751.237% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2765.589% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 203.141% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 162749.732% |
| Orgenesis Inc. | 21.78 Million USD | 637.303% |
| Entera Bio Ltd. | -10.62 Million USD | -1001.195% |
| GH Research PLC | -78.07 Million USD | -49.911% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -425.153% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -339.049% |
| Xencor, Inc. | 29.64 Million USD | 494.839% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -5841.988% |
| Replimune Group, Inc. | 1.41 Million USD | 8389.377% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -47691.824% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 7.413% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -9751.237% |
| Portage Biotech Inc. | -4.98 Million USD | -2249.849% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -520220.071% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -77.015% |
| OncoCyte Corporation | -6.56 Million USD | -1683.422% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 13142.601% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2469.253% |
| Purple Biotech Ltd. | -14.13 Million USD | -727.882% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -392.701% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1688.327% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -601.203% |
| HilleVax, Inc. | -165.48 Million USD | 29.271% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -4511.742% |
| Tharimmune, Inc. | -10.93 Million USD | -970.345% |
| Genprex, Inc. | -6.73 Million USD | -1637.199% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 68.264% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -32.315% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -8254.461% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3428.728% |
| OKYO Pharma Limited | -826.84 Thousand USD | -14055.685% |
| Savara Inc. | 153 Thousand USD | 76600.654% |
| Curis, Inc. | -23.88 Million USD | -389.999% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2169.252% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -14983.014% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1785.406% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 9977.3% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.805% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1048.624% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 80.755% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 36.932% |
| Erasca, Inc. | -37.21 Million USD | -214.505% |
| bluebird bio, Inc. | 108.57 Million USD | 207.806% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -8988.177% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 130.903% |
| DBV Technologies S.A. | -126.98 Million USD | 7.828% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -8988.177% |
| Moderna, Inc. | -2.9 Billion USD | 95.974% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1030.661% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -976.978% |
| Molecular Templates, Inc. | 707 Thousand USD | 16655.304% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -273.103% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 133.769% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -42.631% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -27.598% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -262.686% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -240.488% |
| MacroGenics, Inc. | -66.98 Million USD | -74.735% |
| RenovoRx, Inc. | -1.17 Million USD | -9878.346% |
| Adicet Bio, Inc. | -138.78 Million USD | 15.665% |
| Prime Medicine, Inc. | -27.94 Million USD | -318.904% |
| Aditxt, Inc. | 18.12 Million USD | 745.918% |
| Adagene Inc. | -87.62 Million USD | -33.572% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2709.939% |
| Quantum-Si incorporated | -118.55 Million USD | 1.274% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 425.083% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1466.003% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -141.287% |
| SciSparc Ltd. | -2.06 Million USD | -5568.087% |
| Vericel Corporation | 1.27 Million USD | 9265.701% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -876.058% |
| Minerva Neurosciences, Inc. | 41 Million USD | 385.448% |
| Generation Bio Co. | 31.44 Million USD | 472.189% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 33.255% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -278.508% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 200.389% |
| Invivyd, Inc. | -198.47 Million USD | 41.028% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -29.662% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -4781.619% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -65.343% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1614.96% |
| 2seventy bio, Inc. | 181.71 Million USD | 164.412% |
| ADMA Biologics, Inc. | 90.06 Million USD | 229.956% |
| Clene Inc. | 3.34 Million USD | 3604.371% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1188.669% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -444.122% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1713.939% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 65.987% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -350.182% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 165.88% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2760.664% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2439.984% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2146.996% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 10.175% |
| Evaxion Biotech A/S | 5.28 Million USD | 2313.911% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -3.978% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 10.838% |
| Trevena, Inc. | 2.25 Million USD | 5283.614% |
| Surrozen, Inc. | -32.66 Million USD | -258.333% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -127.23% |
| Cingulate Inc. | 3.08 Million USD | 3896.887% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3885.223% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1728.579% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1159.748% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -47.556% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 10.959% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -10.9% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2868.724% |
| Kronos Bio, Inc. | -36.05 Million USD | -224.641% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1343.979% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8127.147% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -115.729% |
| Statera Biopharma, Inc. | 14.41 Million USD | 911.894% |
| ImmunityBio, Inc. | 618.22 Million USD | 118.933% |
| Korro Bio, Inc. | -132.94 Million USD | 11.958% |
| Kineta, Inc. | -4.54 Million USD | -2477.538% |
| BioVie Inc. | -17.73 Million USD | -560.07% |
| Codexis, Inc. | -43.27 Million USD | -170.495% |
| Celularity Inc. | 65.19 Million USD | 279.546% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3593.468% |
| Celcuity Inc. | 6.78 Million USD | 1825.449% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3378.394% |
| Cibus, Inc. | -8.07 Million USD | -1348.948% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2667.699% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2661.182% |
| IN8bio, Inc. | -16.38 Million USD | -614.174% |
| Kodiak Sciences Inc. | -103.87 Million USD | -12.68% |
| Annexon, Inc. | -193.75 Million USD | 39.591% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 325227.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -568.873% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3231.796% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 111.102% |
| Eyenovia, Inc. | 1.25 Million USD | 9398.944% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 535.034% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3509.189% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -252.05% |
| Arcellx, Inc. | -296.95 Million USD | 60.585% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -500.051% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -98.804% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -464.703% |
| Moolec Science SA | 117.61 Thousand USD | 99615.372% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -204.815% |
| Geron Corporation | 14.76 Million USD | 892.941% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -208.682% |
| Royalty Pharma plc | 5.65 Billion USD | 102.069% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 17.236% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1574.616% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2082.53% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 16.83% |
| Humacyte, Inc. | -22.48 Million USD | -420.528% |
| Structure Therapeutics Inc. | -124.33 Million USD | 5.865% |
| 89bio, Inc. | -289.05 Million USD | 59.507% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -363.695% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -6464.554% |
| Genelux Corporation | -6.89 Million USD | -1596.565% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -276.851% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 240.009% |
| Notable Labs, Ltd. | -9.77 Million USD | -1097.279% |
| Liquidia Corporation | -80.17 Million USD | -45.986% |
| Mustang Bio, Inc. | -3.73 Million USD | -3032.923% |
| Immunovant, Inc. | -635.22 Million USD | 81.574% |
| Quantum-Si incorporated | -118.55 Million USD | 1.274% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -566.397% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2725.151% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1558.154% |
| Acasti Pharma Inc. | -23 Million USD | -408.785% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3376.033% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -620.311% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 15.024% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3655.854% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -426.475% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -530.33% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 30.856% |
| PepGen Inc. | -60.67 Million USD | -92.922% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -409.427% |
| United Therapeutics Corporation | -507.7 Million USD | 76.946% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -511.973% |
| Solid Biosciences Inc. | -47.75 Million USD | -145.123% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -13477.02% |
| Immuneering Corporation | -54.94 Million USD | -113.032% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2684.497% |
| Silo Pharma, Inc. | -3.52 Million USD | -3221.106% |
| Belite Bio, Inc | -87.27 Million USD | -34.118% |
| XOMA Corporation | -29 Million USD | -303.607% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -65.56% |
| Bionomics Limited | 227 Million USD | 151.56% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -0.657% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4520.845% |
| uniQure N.V. | -102.95 Million USD | -13.691% |
| Cassava Sciences, Inc. | -121.13 Million USD | 3.376% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2709.939% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 385.82% |
| Forte Biosciences, Inc. | -11.96 Million USD | -878.564% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -3682.755% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 110520.755% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3509.189% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1414.385% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1478.29% |
| Altimmune, Inc. | -134.48 Million USD | 12.969% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 159.095% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4520.845% |
| Compugen Ltd. | -12.9 Million USD | -807.052% |
| Peak Bio, Inc. | 10.34 Million USD | 1231.956% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -41259.011% |
| Benitec Biopharma Inc. | -50.58 Million USD | -131.399% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -12.18% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 695.806% |
| Zura Bio Limited | -99.8 Million USD | -17.274% |
| PolyPid Ltd. | 6.17 Million USD | 1997.018% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 257.914% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 695.806% |
| Instil Bio, Inc. | 75.35 Million USD | 255.32% |
| argenx SE | -2.02 Billion USD | 94.231% |
| Immunome, Inc. | -97.02 Million USD | -20.63% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -420.32% |
| Verona Pharma plc | -220.44 Million USD | 46.904% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -63.146% |
| Shattuck Labs, Inc. | -121.42 Million USD | 3.606% |
| CervoMed Inc. | -7.79 Million USD | -1401.967% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 36.902% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2576.561% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 11.154% |
| Moolec Science SA | 117.61 Thousand USD | 99615.372% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5015.698% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 836.213% |
| AnaptysBio, Inc. | -18.15 Million USD | -544.846% |
| Design Therapeutics, Inc. | -18.15 Million USD | -544.882% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -66.303% |
| NeurAxis, Inc. | 145.7 Thousand USD | 80433.562% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1142.076% |
| Lumos Pharma, Inc. | -28.49 Million USD | -310.789% |
| Achilles Therapeutics plc | -126.92 Million USD | 7.783% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -63.146% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -17749.725% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -463.43% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8127.147% |
| Nutriband Inc. | -251.65 Thousand USD | -46410.131% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -788.664% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1473.199% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 134.405% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 593.137% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 73.843% |
| Palisade Bio, Inc. | -12.06 Million USD | -870.289% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 16.581% |
| Beam Therapeutics Inc. | -262.72 Million USD | 55.449% |
| Neurogene Inc. | -131.95 Million USD | 11.299% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 636.514% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2298.484% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 68.969% |
| Sesen Bio, Inc. | -112.55 Million USD | -3.992% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -17.21% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -4885.363% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -199.918% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -40.542% |
| Athira Pharma, Inc. | -88.99 Million USD | -31.514% |
| Vaccinex, Inc. | -1.28 Million USD | -8987.422% |
| HCW Biologics Inc. | 2.85 Million USD | 4197.279% |
| XOMA Corporation | -29 Million USD | -303.607% |
| Nektar Therapeutics | 210.24 Million USD | 155.673% |
| Arvinas, Inc. | -313.8 Million USD | 62.7% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7312.196% |
| Merus N.V. | -192.88 Million USD | 39.318% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 295.125% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1587.028% |
| Rezolute, Inc. | -68.16 Million USD | -71.702% |
| Clene Inc. | 3.34 Million USD | 3604.371% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -787.586% |
| BeyondSpring Inc. | -13.75 Million USD | -750.934% |
| Synlogic, Inc. | -6.68 Million USD | -1650.875% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 10421.517% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1284.341% |
| Peak Bio, Inc. | 10.34 Million USD | 1231.956% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -42.012% |
| Krystal Biotech, Inc. | -350.23 Million USD | 66.581% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 194.297% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 30.74% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3607.338% |
| MannKind Corporation | 143.89 Million USD | 181.339% |
| Ikena Oncology, Inc. | -109.15 Million USD | -7.228% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1445.978% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -253.613% |
| Gossamer Bio, Inc. | 180.35 Million USD | 164.898% |
| CohBar, Inc. | -5.93 Million USD | -1873.551% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -293.458% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2663.425% |
| Legend Biotech Corporation | -949.39 Million USD | 87.672% |
| Mural Oncology plc | -255.84 Million USD | 54.251% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 463.328% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2384.714% |
| Disc Medicine, Inc. | -358.28 Million USD | 67.331% |
| Champions Oncology, Inc. | 4.81 Million USD | 2532.377% |
| REGENXBIO Inc. | 54.76 Million USD | 313.712% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -43426.572% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 22.498% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1198.779% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -45.069% |
| Vaxart, Inc. | -8.24 Million USD | -1320.289% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -133.252% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 7.958% |
| Cellectis S.A. | -43.85 Million USD | -166.893% |
| Longeveron Inc. | -2.9 Million USD | -3924.966% |
| Repare Therapeutics Inc. | -107.85 Million USD | -8.519% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 112.087% |
| Inozyme Pharma, Inc. | 12 Million USD | 1075.058% |
| Revolution Medicines, Inc. | -608.2 Million USD | 80.755% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -9415.935% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 55.851% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 22.007% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -648.041% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -15717.027% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.776% |
| Denali Therapeutics Inc. | -74.86 Million USD | -56.343% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -876.058% |
| Veru Inc. | 4.77 Million USD | 2548.677% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -940.779% |
| Cingulate Inc. | 3.08 Million USD | 3896.887% |
| Passage Bio, Inc. | 4.58 Million USD | 2652.803% |
| Context Therapeutics Inc. | -14.44 Million USD | -710.017% |
| Exicure, Inc. | 5.84 Million USD | 2101.128% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 49.193% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -195.795% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 845.944% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -98.987% |
| Nuvalent, Inc. | -335.38 Million USD | 65.101% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 6848.73% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -57.147% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1216.603% |
| OmniAb, Inc. | 9.2 Million USD | 1371.824% |
| Anew Medical, Inc. | 1.43 Million USD | 8270.95% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 814.49% |
| Lipocine Inc. | -4.75 Million USD | -2361.746% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -6.572% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 868.472% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -131.047% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 570.215% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1641.497% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -77.808% |
| Ocugen, Inc. | -32.52 Million USD | -259.909% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -36.776% |
| Q32 Bio Inc. | -37.94 Million USD | -208.438% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -18537.898% |
| Alumis Inc. Common Stock | -13.52 Million USD | -765.149% |
| Equillium, Inc. | -22.39 Million USD | -422.713% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -357.783% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -258.742% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -47112.149% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 187.32% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 3759.975% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 35736.842% |
| Dominari Holdings Inc. | 195 Thousand USD | 60123.59% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2122.29% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1212.616% |
| Bio-Techne Corporation | 267.74 Million USD | 143.715% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -622.105% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 0.887% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1292.907% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -825.192% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 52.249% |
| Nkarta, Inc. | 57.29 Million USD | 304.272% |
| BioCardia, Inc. | 212 Thousand USD | 55310.377% |
| Iterum Therapeutics plc | 13.43 Million USD | 971.008% |